<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Indian J Crit Care Med</journal-id><journal-id journal-id-type="publisher-id">IJCCM</journal-id><journal-title-group><journal-title>Indian Journal of Critical Care Medicine : Peer-reviewed, Official Publication of Indian Society of Critical Care Medicine</journal-title></journal-title-group><issn pub-type="ppub">0972-5229</issn><issn pub-type="epub">1998-359X</issn><publisher><publisher-name>Medknow Publications</publisher-name><publisher-loc>India</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">19881174</article-id><article-id pub-id-type="pmc">2772252</article-id><article-id pub-id-type="publisher-id">IJCCM-13-17</article-id><article-id pub-id-type="doi">10.4103/0972-5229.53110</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>A comparative study to assess the effect of amikacin sulfate bladder wash on catheter-associated urinary tract infection in neurosurgical patients</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Zacharias</surname><given-names>Sumi</given-names></name><xref ref-type="aff" rid="AF0001"/></contrib><contrib contrib-type="author"><name><surname>Dwarakanath</surname><given-names>Srinivas</given-names></name><xref ref-type="aff" rid="AF0002">1</xref><xref ref-type="corresp" rid="cor1"/></contrib><contrib contrib-type="author"><name><surname>Agarwal</surname><given-names>Meena</given-names></name><xref ref-type="aff" rid="AF0001"/></contrib><contrib contrib-type="author"><name><surname>Sharma</surname><given-names>Bhavani Shankar</given-names></name><xref ref-type="aff" rid="AF0002">1</xref></contrib></contrib-group><aff id="AF0001"><bold>From:</bold> College of Nursing, New Delhi, India</aff><aff id="AF0002"><label>1</label>Department of Neurosurgery, All India Institute of Medical Sciences, New Delhi, India</aff><author-notes><corresp id="cor1"><bold>Correspondence:</bold> Dr. Srinivas Dwarakanath, Department of Neurosurgery, All India Institute of Medical Sciences, New Delhi-110 029, India. E-mail: <email xlink:href="dwarakaneuro@yahoo.com">dwarakaneuro@yahoo.com</email></corresp></author-notes><pub-date pub-type="ppub"><season>Jan-Mar</season><year>2009</year></pub-date><volume>13</volume><issue>1</issue><fpage>17</fpage><lpage>20</lpage><permissions><copyright-statement>&#x000a9; Indian Journal of Critical Care Medicine</copyright-statement><copyright-year>2009</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec id="st1"><title>Background:</title><p>The indwelling urinary catheter is an essential part of modern medical care. Unfortunately, when poorly managed, the indwelling catheter may present a hazard to the very patients it is designed to protect. Catheter-associated urinary tract infection (CAUTI) is the most common nosocomial infection in hospitals and nursing homes.</p></sec><sec id="st2"><title>Aims and Objectives:</title><p>The primary objective was to study the effect of amikacin sulfate bladder wash on CAUTI in neurosurgical patients. The other objectives were to study the various organisms causing CAUTI and their antibiotic sensitivity and resistance pattern.</p></sec><sec id="st3"><title>Materials and Methods:</title><p>This was a prospective randomized controlled study performed on 60 patients who met the inclusion criteria at the neurosurgical intensive care of the All India Institute of Medical Sciences between June and December 2006. The patients were randomized into two groups &#x02013; one was the trial group which received amikacin bladder wash, while the other was the control group that did not receive any bladder wash.</p></sec><sec id="st4"><title>Results:</title><p>Forty percent of the subjects in the control group developed CAUTI, while none of the subjects in study group developed CAUTI. (Fisher's exact test, <italic>P</italic> value &#x0003c; 0.001) <italic>Pseudomonas aeruginosa</italic> (51%) was the commonest pathogen.</p></sec><sec id="st5"><title>Conclusions:</title><p>Amikacin sulfate bladder wash was effective in preventing CAUTI. It can thus decrease the antibiotic usage thereby preventing the emergence of antibiotic resistance.</p></sec></abstract><kwd-group><kwd>Amikacin bladder irrigation</kwd><kwd>bladder wash</kwd><kwd>catherer-associated urinary tract infection
</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-1"><title>Introduction</title><p>The indwelling urinary catheter is an essential part of modern medical care and a variety of different indwelling urinary catheters can be used for various purposes. Each year, urinary catheters are inserted in more than five million patients in acute-care hospitals and extended-care facilities.[<xref ref-type="bibr" rid="CIT1">1</xref>]</p><p>Unfortunately, when poorly managed, the indwelling catheter may present a hazard to the very patients it is designed to protect. Catheter-associated urinary tract infection (CAUTI) is the most common nosocomial infection in hospitals and nursing homes, comprising &#x0003e;40% of all institutionally acquired infections.[<xref ref-type="bibr" rid="CIT2">2</xref>&#x02013;<xref ref-type="bibr" rid="CIT6">6</xref>] Interventions such as topical meatal antimicrobials, disinfectants added to the urinary drainage bag, and antimicrobials coatings for catheters have not been shown to decrease the incidence of UTI.[<xref ref-type="bibr" rid="CIT7">7</xref>] An effective measure to prevent the CAUTI has not yet been developed. The most common organisms responsible for CAUTI are <italic>Escherichia coli</italic>, <italic>Candida</italic> spp., <italic>Klebsiella pneumoniae</italic>, <italic>Streptococcus agalactiae</italic>, <italic>Enterococcus faecalis</italic>, and <italic>Pseudomonas aeruginosa</italic>. Amikacin has proven to be the most effective antibiotic in preventing the growth of all these species.[<xref ref-type="bibr" rid="CIT8">8</xref>]</p><p>Previous studies have shown that using individualized regimens for bladder washouts minimizes the infection rate and catheter blockage, thus reducing the need for frequent recatheterization.[<xref ref-type="bibr" rid="CIT9">9</xref>] Since there is no significant systemic absorption of antibiotics used for bladder irrigation,[<xref ref-type="bibr" rid="CIT10">10</xref>] prophylactic bladder irrigations are considered to be safe. We performed an extensive review of literature which did not reveal any study done on the effectiveness of amikacin sulfate bladder wash.</p></sec><sec sec-type="materials|methods" id="sec1-2"><title>Materials and Methods</title><p>This study was performed on a total of 60 catheterized patients who were admitted to the Neurosurgery Department of AIIMS, New Delhi, during June&#x02013;December 2006 and met the inclusion criteria [Appendix 1]. The subject data sheet and procedure of amikacin sulfate bladder wash was developed under the guidance of a guide (Author 3) and co-guides (Authors 2 and 4), and was further validated by six experts from the Departments of Neurosurgery, Microbiology, and Nursing, AIIMS.</p><p>Informed written consent was taken from the patients or patients' relatives after providing appropriate information to the concerned. Confidentiality of the data was ensured. They were randomized after catheterization to either of the two groups &#x02013; study and the control groups. Then urine samples were sent within 24 hours for culture and sensitivity (C/S), in case of positive C/S, patients were excluded from the study [Appendix 2]. Study group received amikacin sulfate bladder wash twice daily under strict aseptic precautions and the control group did not receive bladder wash [Appendix 3]. Urine C/S was performed on days 3, 7, and then weekly till the removal of catheter or discharge. Both groups received standard catheter care including perineal care; the only difference was the bladder wash. The researcher (Author 1) performed the bladder wash on all patients to eliminate bias. CAUTI was diagnosed when it met the respective criteria [Appendix 4].</p><sec id="sec2-1"><title>Statistical methods</title><p>Descriptive and inferential statistical methods were used. Data were analyzed using SPSS-10<sup>th</sup> version. A probability of &#x0003c;0.05 was accepted as significant. For continuous variables having normal distribution, data were summarized using mean&#x000b1;SD, and the groups were compared using independent <italic>t</italic> test. Range and median were used for all continuous variables having non-normal distribution (age and duration of catheterization) and the two groups were compared using Mann-Whitney U test. Frequency and percentage were used for all categorical variables and the groups were compared using Pearson's chi-square test and Fisher's exact test.</p><p>The study was conducted following the approval of ethics committee of All India Institute of Medical Sciences (AIIMS).</p></sec></sec><sec sec-type="result" id="sec1-3"><title>Results</title><sec id="sec2-2"><title>Demographic profile of patients</title><p>Age of the study subjects ranged from 18&#x02013;68 years [<xref ref-type="table" rid="T0001">Table 1</xref>]. The groups were homogenous in terms of age, sex, level of consciousness, size of catheter and duration of catheterization, and systemic usage of steroids and antibiotics. Bladder wash was well tolerated by all the subjects in the study group.</p><table-wrap id="T0001" position="float"><label>Table 1</label><caption><p>Age, sex, and duration of catheterization (n=60)</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Variables</th><th align="center" rowspan="1" colspan="1">Study group <italic>n</italic> = 30</th><th align="center" rowspan="1" colspan="1">Control group <italic>n</italic> = 30</th><th align="center" rowspan="1" colspan="1"><italic>P</italic> value</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age (years)</td><td align="center" rowspan="1" colspan="1">19&#x02013;65 (38)</td><td align="center" rowspan="1" colspan="1">18&#x02013;68 (42.5)</td><td align="center" rowspan="1" colspan="1">0.399</td></tr><tr><td align="left" rowspan="1" colspan="1">Males (%)</td><td align="center" rowspan="1" colspan="1">16 (53)</td><td align="center" rowspan="1" colspan="1">16 (53)</td><td align="center" rowspan="1" colspan="1">1.0</td></tr><tr><td align="left" rowspan="1" colspan="1">Females (%)</td><td align="center" rowspan="1" colspan="1">14 (47)</td><td align="center" rowspan="1" colspan="1">14 (47)</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="left" rowspan="1" colspan="1">Duration of catheterization (days)</td><td align="center" rowspan="1" colspan="1">3&#x02013;29 (7)</td><td align="center" rowspan="1" colspan="1">4&#x02013;20 (8)</td><td align="center" rowspan="1" colspan="1">0.823</td></tr></tbody></table></table-wrap></sec><sec id="sec2-3"><title>Incidence of catheter-associated urinary tract infection and predisposing factors</title><p>Incidence of CAUTI was 40% in the control group [<xref ref-type="fig" rid="F0001">Figure 1</xref>]. None of the subjects from the bladder wash group developed CAUTI. Amikacin bladder wash was effective in preventing CAUTI (<italic>P</italic> &#x0003c; 0.001). Lower levels of consciousness (i.e. the Glasgow coma scale (GCS)) increased the risk of developing CAUTI (<italic>P</italic> = 0.026) [<xref ref-type="table" rid="T0002">Table 2</xref>].</p><fig id="F0001" position="float"><label>Figure 1</label><caption><p>Effect of amikacin sulfate bladder wash on catheter-associated urinary tract infection</p></caption><graphic xlink:href="IJCCM-13-17-g001"/></fig><table-wrap id="T0002" position="float"><label>Table 2</label><caption><p>Risk factors for catheter-associated urinary tract infection (n=60)</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Factors</th><th align="center" rowspan="1" colspan="1">UTI-positive group n = 12</th><th align="center" rowspan="1" colspan="1">UTI-negative group n = 18</th><th align="center" rowspan="1" colspan="1"><italic>P</italic> value</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age (years)</td><td align="center" rowspan="1" colspan="1">18&#x02013;68 (46.5)</td><td align="center" rowspan="1" colspan="1">20&#x02013;55 (41.5)</td><td align="center" rowspan="1" colspan="1">0.280</td></tr><tr><td align="left" rowspan="1" colspan="1">Sex</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">0.457</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Females</td><td align="center" rowspan="1" colspan="1">7 (50)</td><td align="center" rowspan="1" colspan="1">7 (50)</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Males</td><td align="center" rowspan="1" colspan="1">5 (31.3)</td><td align="center" rowspan="1" colspan="1">11 (68.7)</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Motor score of GCS</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">0.026<sup>*</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;M 1&#x02013;3</td><td align="center" rowspan="1" colspan="1">5 (83.4)</td><td align="center" rowspan="1" colspan="1">1 (16.6)</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;M 4&#x02013;6</td><td align="center" rowspan="1" colspan="1">7 (29.2)</td><td align="center" rowspan="1" colspan="1">17 (70.8)</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Catheter size</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">0.131</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;12</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">2 (100)</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;14</td><td align="center" rowspan="1" colspan="1">7 (36.8)</td><td align="center" rowspan="1" colspan="1">12 (63.2)</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;16</td><td align="center" rowspan="1" colspan="1">5 (71.4)</td><td align="center" rowspan="1" colspan="1">2 (28.6)</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;18</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">2 (100)</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Duration of catheterization</td><td align="center" rowspan="1" colspan="1">6&#x02013;20 (9)</td><td align="center" rowspan="1" colspan="1">4&#x02013;14 (7.5)</td><td align="center" rowspan="1" colspan="1">0.135</td></tr><tr><td align="left" rowspan="1" colspan="1">Systemic antibiotics</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">0.255</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Yes</td><td align="center" rowspan="1" colspan="1">12 (44.4)</td><td align="center" rowspan="1" colspan="1">15 (55.6)</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;No</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">3 (100)</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Steroids</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">0.643</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Yes</td><td align="center" rowspan="1" colspan="1">7 (36.8)</td><td align="center" rowspan="1" colspan="1">12 (63.2)</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;No</td><td align="center" rowspan="1" colspan="1">5 (45.5)</td><td align="center" rowspan="1" colspan="1">6 (54.5)</td><td rowspan="1" colspan="1"/></tr></tbody></table></table-wrap></sec><sec id="sec2-4"><title>Organism and sensitivity profile</title><p><italic>P. aeruginosa</italic> was the most common organism responsible for 51% of CAUTI [<xref ref-type="fig" rid="F0002">Figure 2</xref>]. <italic>P. aeruginosa</italic> was completely sensitive to amikacin sulfate, cefaperazone plus sulbactam, and piperacillin plus tazobactam, while it was completely resistant towards ceftazidime.</p><fig id="F0002" position="float"><label>Figure 2</label><caption><p>Pathogens causing catheter-associated urinary tract infection</p></caption><graphic xlink:href="IJCCM-13-17-g002"/></fig></sec></sec><sec sec-type="discussion" id="sec1-4"><title>Discussion</title><p>The present study is the first of its kind in which the effect of amikacin bladder wash has been analyzed. Efficiency of bladder irrigation using various different solutions have been studied in the past in an attempt to reduce the incidence of CAUTI, majority of the investigators found it to be a time consuming and costly procedure that did not have an impact on CAUTI.[<xref ref-type="bibr" rid="CIT11">11</xref>&#x02013;<xref ref-type="bibr" rid="CIT15">15</xref>] In contrast, the present study revealed that amikacin bladder wash is effective in preventing CAUTI. In previous studies, the incidence of CAUTI ranged from 11.0&#x02013;73.3%.[<xref ref-type="bibr" rid="CIT16">16</xref><xref ref-type="bibr" rid="CIT17">17</xref>] In the present study, incidence of CAUTI was 40% since those who were catheterized for less than three days were excluded in the study. This inclusion criterion might be the chief reason for a higher incidence of CAUTI in the present study.</p><p>CAUTI increases the burden of the patient in terms of increased morbidity and mortality, prolonged hospital stay, and cost of the tests and medicines.[<xref ref-type="bibr" rid="CIT17">17</xref>&#x02013;<xref ref-type="bibr" rid="CIT19">19</xref>] Tambyah <italic>et al.</italic>,[<xref ref-type="bibr" rid="CIT20">20</xref>] found that CAUTI had been responsible for an additional of USD589 per CAUTI in diagnostic tests and in medications. The present study reveals that amikacin sulfate bladder wash is effective in preventing CAUTI. As a vial of amikacin sulfate (500 mg) costs INR58 (approximately USD1.4), this is very cost effective especially in a developing country like ours.</p><p>Puri <italic>et al.</italic>,[<xref ref-type="bibr" rid="CIT21">21</xref>] in their study said that the risk was significantly higher for females, elderly patients, critically ill patients, and those on prolonged catheterization. The present study showed only severity of the disease (low motor score of GCS) as a statistically significant risk factor. This might be since a lower GCS corresponds to the severity of tissue injury, where there is hypermetabolism and increased protein catabolism, which eventually leads to decreased immunity that makes the person more susceptible to infections. However, the present study did not show any influence of sex, age, catheter size, duration of catheterization, and systemic use of antibiotics and steroids. This might be because of the small sample size and inclusion of long-term catheterized patients only.</p><p>Pathogenic organisms responsible for CAUTI and their antibiotic sensitivity pattern vary with time. In a study, Jha <italic>et al.</italic>,[<xref ref-type="bibr" rid="CIT22">22</xref>] found that most common organisms responsible for CAUTI were <italic>E. coli</italic> (49%), <italic>S. aureus</italic> (23%), Proteus spp. (3.6%), <italic>Klebsiella</italic> (9.71%), <italic>Pseudomonas</italic> (0.8%), and <italic>Citrobacter</italic> (2.8%). Whereas in the present study, <italic>Pseudomonas</italic> (51%), <italic>E. coli</italic> (17%), <italic>Proteus</italic> spp., <italic>Citrobacter</italic>, <italic>Klebsiella</italic>, and <italic>Acinetobacter</italic> (8% each) were the most common. Similarly, antibiotic resistance pattern also varied. In their study, Taneja <italic>et al.</italic>,[<xref ref-type="bibr" rid="CIT23">23</xref>] found the highest frequency of antibiotic resistance was for ciprofloxacin (68.6%) followed by netilmicin (60.7%), ceftazidime (58.8%), imipenem (43.7%), amikacin (43.1%), and piperacillin (39.2%). In the present study, the pattern of antibiotic resistance was ceftazidime (100%), netilmicin (83%), imipenem (75%), ciprofloxacin (75%), and meropenem (60%).</p><p>In this study, we have shown that amikacin sulfate bladder wash is very effective in preventing CAUTI. Thus it can be included in the routine catheter care, especially if catheterization is needed for more than five days. It is easy to implement and cost effective. The main limitation of this study was the small sample size and the fact that the main researcher was not blinded to the study.</p></sec><sec sec-type="conclusions" id="sec1-5"><title>Conclusions</title><p>There is a varying pattern of antibiotic sensitivity and resistance in different institutions. The most important thing to note is the fact that the bacteria have started developing resistance to higher antibiotics. This is very important since the indiscriminate use of antibiotics can lead to resistance, thus potentially endangering the life of a patient. This increasing resistance calls for immediate measures to use methods other than oral or parenteral antibiotics in CAUTI. We believe that this study is important because if used can decrease the development of CAUTI.</p></sec></body><back><fn-group><fn fn-type="supported-by"><p><bold>Source of Support:</bold> Nil</p></fn><fn fn-type="conflict"><p><bold>Conflict of Interest:</bold> None declared.</p></fn></fn-group><ref-list><title>References</title><ref id="CIT1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kunnin</surname><given-names>CM</given-names></name></person-group><article-title>Genitourinary infections in the patient at risk: Extrinsic risk factors</article-title><source>Am J Med</source><year>1984</year><volume>76</volume><fpage>31</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">6691359</pub-id></element-citation></ref><ref id="CIT2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schaeffer</surname><given-names>AJ</given-names></name></person-group><article-title>Catheter associated bacteriuria</article-title><source>Urol Clin North Am</source><year>1986</year><volume>13</volume><fpage>35</fpage><lpage>47</lpage></element-citation></ref><ref id="CIT3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stamm</surname><given-names>WE</given-names></name></person-group><article-title>Catheter-associated urinary tract infections: Epidemiology, pathogenesis, and prevention</article-title><source>Am J Med</source><year>1991</year><volume>91</volume><fpage>65S</fpage><lpage>71S</lpage><pub-id pub-id-type="pmid">1928194</pub-id></element-citation></ref><ref id="CIT4"><label>4</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Burke</surname><given-names>JP</given-names></name><name><surname>Riley</surname><given-names>DK</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Mayhall</surname><given-names>CG</given-names></name></person-group><article-title>Nosocomial urinary tract infection</article-title><source>Hospital epidemiology and infection control</source><year>1996</year><publisher-loc>Baltimore</publisher-loc><publisher-name>Williams and Wilkins</publisher-name><fpage>139</fpage><lpage>53</lpage></element-citation></ref><ref id="CIT5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Warren</surname><given-names>JW</given-names></name></person-group><article-title>Catheter-associated urinary tract infections</article-title><source>Infect Dis Clin North Am</source><year>1997</year><volume>11</volume><fpage>609</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">9378926</pub-id></element-citation></ref><ref id="CIT6"><label>6</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Kunin</surname><given-names>CM</given-names></name></person-group><article-title>Care of the urinary catheter</article-title><source>Urinary tract infections: Detection, prevention and management</source><year>1997</year><edition>5th ed</edition><publisher-loc>Baltimore</publisher-loc><publisher-name>Williams and Wilkins</publisher-name><fpage>227</fpage><lpage>99</lpage></element-citation></ref><ref id="CIT7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nicolle</surname><given-names>LE</given-names></name></person-group><article-title>Prevention and treatment of urinary catheter-related infections in older patients</article-title><source>Drugs Aging</source><year>1994</year><volume>4</volume><fpage>379</fpage><lpage>91</lpage><pub-id pub-id-type="pmid">8043940</pub-id></element-citation></ref><ref id="CIT8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al Sweih</surname><given-names>N</given-names></name><name><surname>Jamal</surname><given-names>W</given-names></name><name><surname>Rotimi</surname><given-names>VO</given-names></name></person-group><article-title>Spectrum and antibiotic resistance of uropathogens isolated from hospital and community patients with urinary tract infections in two large hospitals in Kuwait</article-title><source>Med Princ Pract</source><year>2005</year><volume>14</volume><fpage>401</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">16220013</pub-id></element-citation></ref><ref id="CIT9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rew</surname><given-names>M</given-names></name></person-group><article-title>Use of catheter maintenance solutions for long-term catheters</article-title><source>Br J Nurs</source><year>1999</year><volume>8</volume><fpage>708</fpage><lpage>15</lpage><pub-id pub-id-type="pmid">10624206</pub-id></element-citation></ref><ref id="CIT10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chamberlain</surname><given-names>G</given-names></name><name><surname>Needham</surname><given-names>P</given-names></name></person-group><article-title>The absorption of antibiotics from the bladder</article-title><source>J Urol</source><year>1976</year><volume>116</volume><fpage>172</fpage><lpage>3</lpage><pub-id pub-id-type="pmid">181601</pub-id></element-citation></ref><ref id="CIT11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dudley</surname><given-names>MN</given-names></name><name><surname>Barriere</surname><given-names>SL</given-names></name></person-group><article-title>Antimicrobial irrigations in the prevention and treatment of catheter-related urinary tract infections</article-title><source>Am J Hosp Pharm</source><year>1981</year><volume>38</volume><fpage>59</fpage><lpage>65</lpage><pub-id pub-id-type="pmid">7011004</pub-id></element-citation></ref><ref id="CIT12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Den Broek</surname><given-names>PJ</given-names></name><name><surname>Daha</surname><given-names>TJ</given-names></name><name><surname>Mouton</surname><given-names>RP</given-names></name></person-group><article-title>Bladder irrigation with povidone-iodine in prevention of urinary-tract infections associated with intermittent urethral catheterisation</article-title><source>Lancet</source><year>1985</year><volume>1</volume><fpage>563</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">2857910</pub-id></element-citation></ref><ref id="CIT13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muncie</surname><given-names>HL</given-names><suffix>Jr</suffix></name><name><surname>Hoopes</surname><given-names>JM</given-names></name><name><surname>Damron</surname><given-names>DJ</given-names></name><name><surname>Tenney</surname><given-names>JH</given-names></name><name><surname>Warren</surname><given-names>JW</given-names></name></person-group><article-title>Once-daily irrigation of long-term urethral catheters with normal saline: Lack of benefit</article-title><source>Arch Intern Med</source><year>1989</year><volume>149</volume><fpage>441</fpage><lpage>3</lpage><pub-id pub-id-type="pmid">2916889</pub-id></element-citation></ref><ref id="CIT14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elliott</surname><given-names>TS</given-names></name><name><surname>Reid</surname><given-names>L</given-names></name><name><surname>Rao</surname><given-names>GG</given-names></name><name><surname>Rigby</surname><given-names>RC</given-names></name><name><surname>Woodhouse</surname><given-names>K</given-names></name></person-group><article-title>Bladder irrigation or irritation?</article-title><source>Br J Urol</source><year>1989</year><volume>64</volume><fpage>391</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">2510901</pub-id></element-citation></ref><ref id="CIT15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schneeberger</surname><given-names>PM</given-names></name><name><surname>Vreede</surname><given-names>RW</given-names></name><name><surname>Bogdanowicz</surname><given-names>JF</given-names></name><name><surname>van Dijk</surname><given-names>WC</given-names></name></person-group><article-title>A randomized study on the effect of bladder irrigation with povidone-iodine before removal of an indwelling catheter</article-title><source>J Hosp Infect</source><year>1992</year><volume>21</volume><fpage>223</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">1353514</pub-id></element-citation></ref><ref id="CIT16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stamm</surname><given-names>AM</given-names></name><name><surname>Coutinho</surname><given-names>MS</given-names></name></person-group><article-title>Urinary tract infection associated with indwelling bladder catheter: Incidence and risk factors</article-title><source>Rev Assoc Med Bras</source><year>1999</year><volume>45</volume><fpage>27</fpage><lpage>33</lpage><pub-id pub-id-type="pmid">10436591</pub-id></element-citation></ref><ref id="CIT17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Danchaivijit</surname><given-names>S</given-names></name><name><surname>Dhiraputra</surname><given-names>C</given-names></name><name><surname>Cherdrungsi</surname><given-names>R</given-names></name><name><surname>Jintanothaitavorn</surname><given-names>D</given-names></name><name><surname>Srihapol</surname><given-names>N</given-names></name></person-group><article-title>Catheter associated UTI</article-title><source>J Med Assoc Thai</source><year>2005</year><volume>88</volume><fpage>S26</fpage><lpage>30</lpage></element-citation></ref><ref id="CIT18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Platt</surname><given-names>R</given-names></name><name><surname>Polk</surname><given-names>BF</given-names></name><name><surname>Murdock</surname><given-names>B</given-names></name><name><surname>Rosner</surname><given-names>B</given-names></name></person-group><article-title>Mortality associated with nosocomial urinary-tract infection</article-title><source>N Engl J Med</source><year>1982</year><volume>307</volume><fpage>637</fpage><lpage>42</lpage><pub-id pub-id-type="pmid">7110215</pub-id></element-citation></ref><ref id="CIT19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adukauskien&#x00117;</surname><given-names>D</given-names></name><name><surname>Kinderyte</surname><given-names>A</given-names></name><name><surname>Rimantas</surname></name><name><surname>Vitkauskiene</surname><given-names>A</given-names></name></person-group><article-title>Etiology, risk factors, and outcome of urinary tract infection</article-title><source>Medicina (Kaunas)</source><year>2006</year><volume>42</volume><fpage>805</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">17090979</pub-id></element-citation></ref><ref id="CIT20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tambyah</surname><given-names>PA</given-names></name><name><surname>Maki</surname><given-names>DG</given-names></name></person-group><article-title>Catheter-associated urinary tract infection is rarely symptomatic: A prospective study of 1,497 catheterized patients</article-title><source>Arch Intern Med</source><year>2000</year><volume>160</volume><fpage>678</fpage><lpage>82</lpage><pub-id pub-id-type="pmid">10724054</pub-id></element-citation></ref><ref id="CIT21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Puri</surname><given-names>J</given-names></name><name><surname>Mishra</surname><given-names>B</given-names></name><name><surname>Mal</surname><given-names>A</given-names></name><name><surname>Murthy</surname><given-names>NS</given-names></name><name><surname>Thakur</surname><given-names>A</given-names></name><name><surname>Dogra</surname><given-names>V</given-names></name><etal/></person-group><article-title>Catheter associated urinary tract infections in neurology and neurosurgical units</article-title><source>J Infect</source><year>2002</year><volume>44</volume><fpage>171</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">12099744</pub-id></element-citation></ref><ref id="CIT22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jha</surname><given-names>N</given-names></name><name><surname>Bapat</surname><given-names>SK</given-names></name></person-group><article-title>A study of sensitivity and resistance of pathogenic microorganisms causing UTI in Kathmandu valley</article-title><source>Kathmandu Univ Med J</source><year>2005</year><volume>3</volume><fpage>123</fpage><lpage>9</lpage></element-citation></ref><ref id="CIT23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taneja</surname><given-names>N</given-names></name><name><surname>Meharwal</surname><given-names>SK</given-names></name><name><surname>Sharma</surname><given-names>SK</given-names></name><name><surname>Sharma</surname><given-names>M</given-names></name></person-group><article-title>Significance and characterisation of pseudomonads from urinary tract specimens</article-title><source>J Commun Dis</source><year>2004</year><volume>36</volume><fpage>27</fpage><lpage>34</lpage><pub-id pub-id-type="pmid">16295683</pub-id></element-citation></ref></ref-list><app-group><app><title>Appendix 1</title><p><bold>Inclusion criteria</bold></p><list list-type="bullet"><list-item><p>Informed consent</p></list-item><list-item><p>Age above 18 years</p></list-item><list-item><p>Patients available within 24 hours of catheterization</p></list-item></list></app></app-group><app-group><app><title>Appendix 2</title><p><bold>Exclusion criteria</bold></p><list list-type="bullet"><list-item><p>Past history of recurrent UTI</p></list-item><list-item><p>Urine culture positive within 24 hours after enrolment in to the study</p></list-item><list-item><p>Immunocompromized patients (AIDS, chemotherapy)</p></list-item><list-item><p>History of diabetes</p></list-item><list-item><p>Patients with renal insufficiency</p></list-item><list-item><p>Catheter removed before third day</p></list-item></list></app></app-group><app-group><app><title>Appendix 3</title><p><bold>Amikacin sulfate bladder wash</bold></p><p>Hundred milligrams amikacin sulfate is added to 500 ml normal saline and 250 ml of this solution is instilled into the bladder through a Foleys catheter (with drainage tube clamped) using an IV set. Solution is allowed to remain in the bladder for 15 minutes and then drained. This is done twice daily.</p></app></app-group><app-group><app><title>Appendix 4</title><p><bold>Catheter-associated urinary tract infection&#x02013;</bold></p><p>The diagnosis of catheter-associated urinary tract infection can be made when the urine culture shows 10<sup>5</sup> CFU/ml of urine from a catheterized patient.</p></app></app-group></back></article>